Metabolomics facilitate the personalized management in inflammatory bowel disease

Inflammatory bowel disease (IBD) is a gastrointestinal disorder characterized by chronic relapsing inflammation and mucosal lesions. Reliable biomarkers for monitoring disease activity, predicting therapeutic response, and disease relapse are needed in the personalized management of IBD. Given the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rirong, Zheng, Jieqi, Li, Li, Li, Chao, Chao, Kang, Zeng, Zhirong, Chen, Minhu, Zhang, Shenghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721420/
https://www.ncbi.nlm.nih.gov/pubmed/34987610
http://dx.doi.org/10.1177/17562848211064489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721420/
https://www.ncbi.nlm.nih.gov/pubmed/34987610
http://dx.doi.org/10.1177/17562848211064489

Ejemplares similares